• About us
• Contact

Advertisement

Product › Details

small-molecule drug

	Next higher product group	pharmaceutical

Record changed: 2026-04-24

Advertisement

More documents for small-molecule drug

• [1] Boehringer Ingelheim. (2/26/26). "Press Release: Boehringer Ingelheim Licenses Novel Oral Therapeutics Program for Immune Diseases from Sitryx Therapeutics". Ingelheim, Oxford & Boston, MA....
• [2] Camp4 Therapeutics Corporation. (12/18/25). "Press Release: Camp4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries". Cambridge, MA....
• [3] Protego Biopharma, Inc.. (12/1/25). "Press Release: Protego Biopharma Raises $130 Million Oversubscribed Series B Financing to Advance First-in-Class AL Amyloidosis Program into Pivotal Study". San Diego, CA....
• [4] Skyhawk Therapeutics, Inc.. (8/18/25). "Press Release: Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders". Boston, MA....
• [5] Secarna Pharmaceuticals GmbH & Co. KG. (7/10/25). "Press Release: Secarna Pharmaceuticals and Vect-Horus Announce Research Collaboration to Advance Systemic Delivery of RNA-Targeted Therapeutics for CNS Disorders". Martinsried & Marseille....
• [6] Mosanna Therapeutics, Inc.. (6/9/25). "Press Release: Mosanna Therapeutics Launches with $80 Million to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea". Redwood City, CA....
• [7] Umlaut.bio GmbH. (5/13/25). "Press Release: Umlaut.bio Publishes in Cell the Foundational Science Behind its First-in-biology Therapies Targeting tRNA Modifications". Heidelberg....
• [8] Isopmorphic Labs Ltd.. (2/18/25). "Press Release: Isomorphic Labs Announces Novartis Collaboration Expansion". London....
• [9] Alesta Therapeutics B.V.. (1/8/25). "Press Release: Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases". Leiden....
• [10] LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.